Bozor qiymatining balans qiymatiga nisbati: Avenue Therapeutics Inc (ATXI)
Avenue Therapeutics Markaziy Nerv Tizimi (CNS) buzilishlari va epilepsiyaning kam uchraydigan shakllarini davolash uchun innovatsion terapiyalarni ishlab chiqadi. Murakkab birikmalarning ishlab chiqarilishi CMOlar orqali xalqaro autsorsingga tayanadi. Balans kapitalining bozor qayta baholash koeffitsiyenti qiymat dinamikasini namoyish etadi, bunda 0.26 yangi darajani qayd etmoqda. Biznesning kengayish imkoniyati aktivlari kam bo'lgan model orqali ta'minlanadi, unga ko'ra dori vositalarini tijoratlashtirish hamkor taqsimot tarmoqlari orqali rejalashtirilgan.
Avenue Therapeutics Inc. (ATXI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Avenue Therapeutics|ATXI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc|ATXI - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Avenue Therapeutics, Inc|ATXI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Avenue Therapeutics|Tezkor likvidlik koeffitsiyenti avenuetx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Avenue Therapeutics - ATXI
Avenue Therapeutics (ATXI) kredit sifatini baholash uchun tahlilchi biznesning bozor qiymatini uning sof aktivlari bilan solishtiradi. Emitentning barqarorligi aksiyalar opsion tizimi orqali yetakchi olimlarni jalb qilish va R&D tashabbuslarining erkinligi bilan mustahkamlanadi. GURU.Markets platformasidagi P/BV koeffitsiyenti tarixi bozorning buxgalteriya qiymatidan yuqori ekanligini aks ettirib, aksiya narxlari va fundamental ko'rsatkichlar o'rtasidagi spekulyativ uzilishni ochib beradi. Ushbu metrikaning o'sishi investorlarning markaziy nerv tizimi (CNS) terapiyasi bo'yicha kelgusi innovatsiyalarga bo'lgan optimizmini bildiradi. Ushbu barqaror tendentsiya kompaniyaning adolatli qiymatini prognoz qilish uchun mezon bo'lib xizmat qiladi.
Raqobatchilar tahlili
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|NBIX - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited|Kapitallashuvning balans qiymatiga nisbati AXSM (Axsome)|Bozor kapitallashuvining balans qiymatiga nisbati ACAD|XENE - Bozor qiymatining balans qiymatiga koeffitsiyenti|Viking Therapeutics - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati supernus.com SUPN|CPRX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati DNLI (Denali)|Harmony Pharma (HRMY) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Biohaven Corp (BHVN)|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati trevitherapeutics.com|Kapitallashuvning sof aktivlarga nisbati PRAX (Praxis Precision Medicines, Inc.)|Bozor qiymatining balans qiymatiga nisbati AVXL (Anavex)|Bozor kapitallashuvining balans qiymatiga nisbati CBLL (CeriBell Corp)|Prothena (PRTA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ALEC - Bozor qiymatining balans qiymatiga nisbati|ANNX (annexonbio.com) - Kapitallashuvning balans qiymatiga nisbati|OMER (omeros.com) - Kapitallashuvning sof aktivlarga nisbati|Neurogene Inc (NGNE) - Bozor kapitallashuvining balans qiymatiga nisbati|ACIU (AC Immune Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Voyager Corp VYGR|Kapitallashuvning sof aktivlarga nisbati NMRA (Neumora Therapeutics)|SCLX (scilexholding.com) - Balans qiymatiga nisbatan bozor qiymati|Tevogen Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori ACOG (Alpha Cognition Inc)|Cognition Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IKT (Inhibikase Pharma)|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Assertio (ASRT)|Bozor qiymatining balans qiymatiga nisbati Coya Therapeutics Inc|VTGN: Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati OVID|Bozor kapitallashuvining balans qiymatiga nisbati Acumen Pharmaceuticals, Inc (ABOS)|Bozor qiymatining balans qiymatiga nisbati CervoMed Inc. CRVO|ATHE (Alterity Therapeutics Ltd.) - Sof aktivlarga nisbatan bozor kapitallashuvi|Clene Nanomedicine - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PepGen Inc.|JUNS (Jupiter Neurosciences) - Kapitallashuvning sof aktivlarga nisbati|Relmada Corp (RLMD) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati ANVS|GRCE (Grace Tx) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati AIFF|Balans qiymatiga nisbatan bozor kapitallashuvi anewmeds.com|Bozor kapitallashuvining balans qiymatiga nisbati NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Kapitallashuvning sof aktivlarga nisbati|MTVA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi neuraxis.com NRXS|HSDT: Bozor kapitallashuvining balans qiymatiga nisbati|Passage Bio (PASG) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NEUP|NERV (Minerva) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati ATHA (Athira Pharma, Inc.)|addextherapeutics.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (Alzamend Neuro)|Balans qiymatiga nisbatan bozor kapitallashuvi Cyclerion Therapeutics Inc. (CYCN)|PTIX - Bozor qiymatining balans qiymatiga nisbati|KTTA (Pasithea Therapeutics) - Kapitallashuvning balans qiymatiga nisbati|CRGT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti brainstorm-cell.com (BCLI)|Kapitallashuvning sof aktivlarga nisbati CARA|Bozor kapitallashuvining balans qiymatiga nisbati Chromocell Therapeutics Corp|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics (ELYM)|ITCI (intracellulartherapies.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Longboard Pharmaceuticals LBPH|marinuspharma.com (MRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGen Biotech - Bozor kapitallashuvining balans qiymatiga nisbati|NRBO - Bozor kapitallashuvining balans qiymatiga nisbati|SAGE (Sage Therapeutics, Inc) - Kapitallashuvning sof aktivlarga nisbati|SNPX (Synaptogenix, Inc) - Bozor qiymatining balans qiymatiga nisbati|TRVN (Trevena, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro VIGL|Bozor qiymatining balans qiymatiga nisbati Anew Medical, Inc. (WENA)|Cerevel Therapeutics Inc - Kapitallashuvning balans qiymatiga nisbati